Pfizer (PFE) stock is in focus as a trial for the company's Elrexfio multiple myeloma drug hit the main goal with patients on ...
With an annual dividend yield of 6.37%, Pfizer Inc. (NYSE:PFE) is included among the 10 Best Fortune 500 Dividend Stocks to ...
The pharmaceutical company has been investing in its future growth, but whether its efforts will pay off is a big question ...
Pfizer Inc. PFE on Wednesday shared topline results from the late-stage study of its cancer treatment, ELREXFIO (elranatamab) ...
Pfizer continues delivering consistent earnings beats, driven by cost-cutting initiatives and improving margins. Learn more ...
The latest trading day saw Pfizer (PFE) settling at $26.8, representing a -1.87% change from its previous close.
View Pfizer Inc. PFE stock quote prices, financial information, real-time forecasts, and company news from CNN.
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...
Pfizer Inc. (NYSE:PFE) on Friday released results from the Phase 3 THRIVE-131 study evaluating inclacumab, an investigational P-selectin inhibitor, in patients 16 years of age and older with sickle ...
In this article, we will discuss the 9 Most Active US Stocks to Buy Right Now. On April 29, Joe Amato, Neuberger President ...